Conversations in Science with the Disruptors Leading the Way
CHDI and Charles River Partnership
Charles River and CHDI Foundation began working together in 2005 on drug discovery and development for Huntington’s Disease. Charles River is proud to have collaborated with CHDI through multiple stages of their preclinical work, from early target identification and drug discovery in our labs to later-stage in vivo studies at our site in Finland. Currently, our work together is focused on new imaging tracers that can label huntingtin pathology in the human brain—and what we hope will be a promising advance for Huntington’s treatment.